My Companies
Notification
Account
Board approved exploring sale of leasehold land and building at Unit-2, Vapi and convening EGM for approval. Unit did Rs 74.46 Cr revenue, 32% of total. No buyer, price or timeline fixed. First asset-sale restructuring move while under lender enforcement and cash strain. Selling one of two Vapi units is a step change from pending merger plan and shrinks core malaria API base. Buyer, price, valuation, use of proceeds and scope whether plant ops included undisclosed. Needs EGM and regulatory nods plus lender stance; survival impact unclear.